Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide

NH4F Modified Al-SBA-15 Materials for Esterification of Valeric Acid to Alkyl Valerates

Al-SBA-15 materials were functionalized by ball milling with several niobium loadings (0.25–1 wt.%) and/or with several F- loadings, using NH4F as a precursor. The catalysts synthesized in this study were characterised by X-ray diffraction (XRD), N2 porosimetry, and diffuse reflection infrared spectroscopy (DRIFT) among others. The prepared materials shown, form moderate to high catalytic activities in the microwave-assisted transformation of valeric acid to ethyl valerate via esterification. The incorporation of fluoride anions either into Al-SBA-15 or on Nb1%/Al-SBA-15 led to a linear increase in valeric acid conversion with the F− content. Thus, F− modified mesoporous aluminosilicates efficiently catalyze the transformation of valeric acid into alkyl valerate esters as renewable fuels